IgoCheck
Colorectal Cancer Recurrence & Therapy Monitoring
CommercialActive
Key Facts
Indication
Colorectal Cancer Recurrence & Therapy Monitoring
Phase
Commercial
Status
Active
Company
About Milagen
Milagen, founded in 2015 and based in San Francisco, is a diagnostics company developing blood-based tests for the early detection of cancer recurrence and therapy monitoring. Its core technology is a proprietary proteomics platform used to discover and validate protein biomarkers found in blood serum. The company currently offers two CLIA lab tests, MammoCheck for breast cancer and IgoCheck for colorectal cancer, with a pipeline targeting lung, ovarian, and prostate cancers. Led by a scientifically experienced team, Milagen operates as a private, likely pre-revenue entity seeking partnerships and investment to advance its product portfolio.
View full company profile